In this special episode of LSP, we sit down with not one but two women from the Multidisciplinary Association of Psychedelic Studies - Public Benefit Corporation (MAPS PBC), where they study the use of MDMA and psilocybin to treat mental health disorders. Allison Coker, PhD is trained in neuroscience and is the regulatory affairs manager. She shares the intricacies of their latest, groundbreaking results from a Phase 3 trial studying the use of MDMA-assisted therapy for the treatment of post-traumatic stress disorder, a study that resulted in 67% of participants no longer qualifying for a PTSD diagnosis. Alia Lilienstein, MD, is the Medical Director of MAPS PBC and shares her career journey from public health, to practicing physician to something unexpected. We think you will learn a lot from these two amazing women!

Special thank you to my colleague, Alex Croft, who inspired me to do this interview and guest starred in it as well. Thank you Alex for your curiosity and inspiration!

Links for the episode:

Learn more about MAPS PBC here: https://mapspublicbenefit.com/

Allison’s LinkedIn: https://www.linkedin.com/in/allisoncoker/

Alia’s LinkedIn: https://www.linkedin.com/in/alia-lilienstein-b4926a97/

This episode is sponsored by Kendall Investor Relations. Check out their open positions here:

https://www.kendallinvestorrelations.com/careers

Support the podcast: https://www.patreon.com/ladyscientistpodcast

All links: https://www.ladyscientistpodcast.com